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Recent advances in gold nanoparticles for
biomedical applications: from hybrid structures
to multi-functionality
Hyeon-Ho Jeong, ab Eunjin Choi,a Elizabeth Elliscd and Tung-Chun Lee *ce
Gold nanoparticles (Au NPs) are arguably the most versatile nanomaterials reported to date. Recent
advances in nanofabrication and chemical synthesis have expanded the scope of Au NPs from classical
homogeneous nanospheres to a wide range of hybrid nanostructures with programmable size, shape
and composition. Novel physiochemical properties can be achieved via design and engineering of the
hybrid nanostructures. In this review we discuss the recent progress in the development of complex
hybrid Au NPs and propose a classification framework based on three fundamental structural
dimensions (length scale, complexity and symmetry) to aid categorising, comparing and designing
various types of Au NPs. Their novel functions and potential for biomedical applications will also be
discussed, featuring point-of-care diagnostics by advanced optical spectroscopy and assays, as well as
minimally invasive surgeries and targeted drug delivery using multifunctional nano-robots.
1. Introduction
Gold nanoparticles (Au NPs) are typically defined as particles of
1–100 nm in size,1 which is in the sub-wavelength regime of
visible light. They often find applications in biology and
medicine owing to their unique physiochemical properties,
including their small and tailorable size, high chemical stabi-
lity and biocompatibility, availability via facile liquid-phase
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synthesis and surface modification, and unique optical
properties.2,3
Similar to their bulk analogue, Au NPs are well-known for
their chemical stability. In particular, they are generally stable
against oxidation under physiological conditions (incl. variable
pH, ionic strength and temperature) without any major risk of
leaching of toxic species.4 Meanwhile, the surface of Au NPs can
be easily functionalised by a wide variety of ligands via thiol or
amine chemistry. These two properties enable Au NPs to be
utilised as an ideal nanoscale platform for drug and gene
delivery amongst a range of nanocarriers.5
Nevertheless the key characteristic that distinguishes Au
NPs frommany other nanomaterials, in the biomedical context,
is their unique optical properties resulting from a physical
phenomenon known as localised surface plasmon resonance
(LSPR),6 which is present typically in nanostructures of plasmonic
materials, such as gold, silver, copper and aluminium. LSPR
involves coherent oscillation and excitation of conduction-band
electrons on the surface of plasmonic nanostructures, such as Au
NPs, upon irradiation of light in the ultraviolet-visible-near infrared
(UV-VIS-NIR) spectral region.
In the context of light–matter interaction, LSPR is typically
stronger than that of small molecules because of a better match
in length scale between the travel distance of localised surface
plasmon and the wavelength of UV-vis-NIR light and the large
polarisability of plasmonic materials at optical frequency. LSPR
accompanies optical near-field enhancement that interacts
with the medium surrounding a nanoparticle.7 This distinctive
optical interaction affects the associated far-field spectral reso-
nance signal and, at the same time, can generate heat locally.8
The strong interaction with light facilitates the use of Au NPs as
nano-antennae for revealing optical properties of the nanoscale
environment around the nanoparticles, leading to various types
of sensing applications,9 as well as for nanolithography,10 photo-
thermal therapy,4 object trapping,11 and nanoscale propulsion
via thermophoretic effect.12
The conditions for the occurrence of LSPR are known to
be highly sensitive to the three-dimensional (3-D) geometric
parameters (e.g. size, shape and symmetry), the material com-
position and distribution within a NP, as well as the overall
arrangement of NPs within an ensemble or array.13,14 In
particular, dipolar LSPR of individual spherical Au NPs occurs
in the visible region ofB520–540 nm and can be shifted to the
NIR region in the case of elongated NPs (i.e. large shape
anisotropy) or assemblies of NPs with nano-spacing. As a result,
optical properties of Au NPs (e.g. peak position, bandwidth and
the number of resonant modes) can be engineered by designing
and optimising structural and material dimensions to suit a
specific biomedical application, as illustrated in Fig. 1.
In addition to tailoring the optical properties, incorporation
of other functional materials onto a Au NP construct can also
introduce other physiochemical properties/functionalities,
including magnetism, stimuli-responsiveness, antifouling and
Fig. 1 Scheme showing functionalities of hybrid Au NPs achieved by
engineering their structural dimensions for biomedical applications.
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cell targeting.15–17 The combination of two or more molecular
ligands, polymer coatings and inorganic materials can lead to
multifunctional hybrid NPs which can show superior performance
in coping with complex biological environments. The facile
chemistry in synthesis and functionalisation of Au NPs makes
them a promising nano-scaffold for constructing hybrid NPs
with multi-functionality.18 Nevertheless, producing bespoke
complex shapes with programmable material distribution at
the nanoscale remains a challenge because minimisation of
surface energy and crystallisation forces generally leads to highly
symmetric and homogeneous nanostructures.19
Recent advances in chemical synthesis and 3-D nanofabrication
techniques oﬀer new promise in the production of complex
hybrid Au NPs in practical quantity and quality. These novel
hybrid nanoparticles give rise to multi-functionality which opens
up exciting opportunities in their biomedical applications.
Unlike previous reviews on Au NPs’ synthesis and biomedical
applications,2,3,20,21 we here highlight recent development of
complex ‘hybrid’ Au NPs. First, we propose a classification
framework for gold nanostructures based on three fundamental
structural dimensions (length scale, complexity and symmetry)
for classifying and designing novel gold nanostructures. The
framework can also be extended to classify other type of NPs.
The second part of the review is dedicated to discussing key
physiochemical properties exhibited by novel hybrid Au NPs, and
their potential biomedical applications, featuring brand-new
functions that are unachievable using conventional Au NPs, for
instance, direct measurement of blood plasma viscosity at
human haematocrit level (ca. 50%) and active drug delivery
using self-propelling nanomotors.
2. Classification framework
The past two decades have witnessed a boom in the develop-
ment of complex hybrid Au NPs. Despite classical gold nano-
spheres being the primary choice in many biomedical research
and applications, an increasing number of complex Au NPs
have become commercially available, ranging from nanorods to
nanocubes and Au–SiO2 core–shell NPs, with various types of
bespoke surface coating. Meanwhile novel hybrid Au nano-
structures are being reported in the scientific community at
an impressive rate (see Section 4 for details).
With an aim of gaining a clear overview of the highly diverse
hybrid gold nanostructures, we propose a classification frame-
work based on three fundamental structural dimensions,
namely length scale, complexity and symmetry. Meanwhile gold
nanostructures are grouped into three main classes, namely (1)
homogeneous Au NPs, (2) heterogeneous Au NPs and (3) Au NP
assemblies, according to their length scale and the material’s
complexity. Representative subclasses can then be organised
with respect to each other according to the structural dimen-
sions, as shown in Fig. 2.
This classification framework can aid comparison and
design of nanomaterials in a systematic fashion. While many
existing examples of gold nanomaterials are not featured in the
scheme owing to limitation of space, other nanostructures can
be readily inserted into the framework by benchmarking against
examples in the scheme based on the fundamental structural
parameters. For instance, Au nanostars are low symmetry and
made of pure gold,22 so they can be positioned between rods
(Fig. 2b) and helices (Fig. 2c). Detailed discussions on the three
main classes can be found in Section 2.4.
The relevance of the structural dimensions to the potential
biomedical applications of the nanomaterials and the corres-
ponding consideration about nanomaterials design will be
briefly discussed below.
2.1 Length scale
The length scale of an individual gold nano-object typically lies
in the range of 1–100 nm, and that of composite and self-
assembled nanostructures generally spans a much wider range
up to the micron regime. While length scale in this context
refers to the overall size of a nano-object, it is noted that, in the
case of hierarchical nanostructures, a nano-object can have a
feature size much smaller than the overall length scale of the
NP. For instance, the Janus Co–Au multilayer coated NPs
(overall size B100 nm) consist of alternate layers of gold
(6 nm) and cobalt (1 nm) as shown in Fig. 2e.23
The overall size of a nanoparticle will have major eﬀects on
cellular interactions and in vivo pharmacokinetics, including
cellular uptake, blood circulation half-life, biodistribution and
tumour permeability.24 For prolonged blood circulation half-
life, the NPs should be within the size window of 10–150 nm. In
cases where rapid renal clearance is desirable, the NPs should
be smaller than 10 nm, which is the effective cut-off size of the
Fig. 2 Hybrid Au nanoparticles. (a) Clusters,47 (b) single crystal nanowire,52
(c) chiral NPs,31,45 (d) core–shell NPs,27 (e) Janus NPs,23 (f) alloyed NPs,142,174
(g) plasmonic meta-molecules,175 (h) DNA-origami templated assemblies,25
(i) large-scale assemblies of NPs.99,176 Adapted by permission from the
corresponding references. Copyright American Chemical Society, Springer
Nature, Wiley-VCH.
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renal filtration barrier. Within the size window, larger nano-
particles tend to have lower colloidal stability owing to the large
van der Waals interactions between them. To screen the
attractive interactions and therefore enhance the colloidal
stability in aqueous media, coating the surface of nanoparticles
with appropriate materials (e.g. hydrophilic small molecules
for small Au NPs, highly hydrophilic polymers or inorganic
materials for large Au NPs) is generally required for most
in vitro and in vivo applications.
2.2 Material complexity
Complexity here refers to the number of types of materials and
molecules within a given nanostructure and the degree of order
amongst individual components. Simple systems typically consist
of homogeneous Au NPs stabilised by a single type of ligand,
whereas complex systems can involve 4200 molecularly precise
components as found in DNA-origami templated Au NP assemblies
(Fig. 2h).25
The purpose of incorporating other materials and molecular
components in a gold nanostructure is to address basic design
requirements of the service life cycle of a given biomedical
application, as well as to introduce multiple functionalities
within a single nanostructure.
Service life cycle design is particularly crucial for in vivo
applications. In addition to considerations on NP size discussed
in Section 2.1, a number of requirements, many of them non-
negotiable, have to be fulfilled when designing hybrid Au NPs. For
instance, the NPs have to be water-soluble, colloidally stable and
biocompatible. On top of that, the NPs have to perform the pre-
defined function specifically and eﬃciently. Since biological
systems are highly complex in nature, the ideal NPs will need to
cope with the complex environment while being transported to
the target region and trigger a specific task on-demand. This can
only be achieved by incorporating and optimising multiple func-
tionalities from various functional molecular, polymeric and
material components on the NP platform.
Furthermore, entirely new properties and functions can
arise by carefully combining functional materials. For instance,
forming the Pt layer surrounding Au NPs permits detection of
p24, one of the earliest and most conserved biomarkers of
human immunodeficiency viruses (HIV), via lateral flow immu-
noassay in 20 min with 104–105 of the molecular dynamic range
(roughly two-fold larger than the commercial products).26 This
is not possible with either material alone.
The production of hybrid Au NPs can be achieved by various
approaches. The simplest route is via a linear series of stepwise
reactions, such as the formation of core–shell nanostructures by
growing a layer of material around the Au NP core (Fig. 2d).27,28
The shell layer can then be further functionalised by another
material or ligand. However, the level of complexity and struc-
tural diversity can be limited by the yield of each step in the
series. This issue can be overcome by using either a convergent
approach or a divergent approach, both of which have been
commonly used in synthesis of complex organic molecules.
The convergent approach involves the synthesis of individual
components, followed by the combination of all individual
components to form the final product. This is an eﬀective way
to increase the degree of complexity of a nanostructure without
compromising the synthetic yield. Supramolecular self-assembly is
often employed in the final step of combining individual compo-
nents because of its mild reaction conditions and the tendency to
reach the desired state of thermodynamic equilibrium via dynamic
exchange of supramolecular bonds. The latter is particularly
important to the successful formation of highly complex structures
which is prone to inhibition by kinetically trapped states. For
instance, the synthesis of DNA-origami templated assemblies
(Fig. 2h) was typically performed via the preparation of functional
Au NPs and the DNA-origami scaﬀold, followed by the combination
step via aqueous self-assembly.25
The divergent approach involves the initial synthesis of an
intermediate which can subsequently be converted into a wide
range of nanostructures. This approach can eﬃciently produce a
library of chemically or structurally related nanostructures.
Examples include structurally similar Au nanocages from Ag
nanocubes,29 as well as Au NPs coated by a mixed self-assembled
monolayer with various ligand composition from surfactant-
stabilised Au NPs.30
On top of the above approaches, the conflict between yield
and complexity of hybrid Au NP synthesis can be tackled by
fundamentally developing fabrication techniques with (close to)
quantitative yield. For instance, nanoscale glancing angle deposi-
tion (nano-GLAD) is a novel 3-D nanofabrication technique that
allows direct growth of hybrid Au NPs (and other nanostructures) in
a parallel manner, producing Au NPs with high degree of complex-
ity of a practical amount.31,32 In contrast, dip-pen lithography,
which is a nanoscale printing technique, can be used to fabricate
increasingly complex hybrid NPs, but the throughputs remain
insuﬃcient for the practical use.33,34
2.3 Symmetry and chirality
Symmetry of a discreet nano-object can be classified based on
symmetry point groups (K for a perfect sphere, DNh for a rod,
CNv for a Janus particle, C2 for a helix and C1 if there does not
exist any symmetry element other than C1 which is equivalent
to the identity element E). In general, a nanostructure is
referred as less symmetric if it belongs to a point group with
fewer symmetry elements.
For a given symmetry, the aspect ratio of a nanostructure
describes the ratio between the length of the structure along
the principle axis (i.e. that of highest rotational symmetry) to
the width perpendicular to the principle axis. The aspect ratio is
reflected as the shape factor w in the Mie solution to the
Maxwell equation, where the conditions of a particular LSPR
mode are given as er = wem.7 Here, er is the real dielectric
constant of metal NP and em is a refractive index of the
surrounding medium. For sphere, w = 2 while for rod 42. It
is noted that LSPR can be red-shifted to the NIR range with
increasing shape factor (i.e. aspect ratio) of the nanostructure,
which can be useful for in vivo applications due to the long
penetration depth of NIR radiation through skin and tissue.
Moreover, sensitivity of a plasmonic sensor also increases with
the shape factor and thus the resonance wavelength of the LSPR
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mode (Section 3.1.1); meanwhile background fluorescence gen-
erally decreases with increasing excitation wavelength in surface-
enhanced Raman scattering measurements (Section 3.1.2). Both
of these cases benefit from shifting the LSPR to the NIR regime.
Nevertheless, the use of NIR light accompanies a reduction in
spatial resolution of the sensing probe, as well as expensive and
complex optical settings. Therefore, optimisation based on case-
specific design constraints is often required in practical
scenarios.
Decreasing the symmetry of a nanostructure can give rise to
interesting optical eﬀects. In particular, a nanostructure is
classified as chiral if it falls into any of the low symmetry point
groups without a plane of symmetry (C1, C2, C3, D2, D3). As the
shape of chiral Au NPs (Fig. 2c) cannot be superimposed onto
its mirror image by simple rotation or translation, they exhibit
chiroptical eﬀects near the frequency of the LSPR. Despite the
presence of analogous chiroptical eﬀects in pure enantiomers
of chiral small molecules, chiroptical eﬀects originated from
LSPR are typically orders of magnitude more pronounced
because of their strong light–matter interaction. As a result,
chiral Au NPs find potential applications in background-
free optical sensing in optically dense bio-media (Sections 3.1
and 3.3), as well as environmental toxins in complex sample
mixtures such as soil.
Another unique property of chiral NPs is the strong coupling
between rotational and translational motion in fluid media. For
instance, when a helical NP is rotating unidirectionally around
its long-axis, it can produce linear propulsion force and trans-
late in a single direction through a fluid, despite the presence
of strong Brownian forces at the nanoscale. Furthermore, this
type of rotation breaks the time-reversal symmetry of the
system, and therefore enables the helical NP to propel through
media at the low Reynolds number regime, which is a scenario
when viscous forces dominate over inertia and is common
among micro- and nanoscale systems. This propulsion strategy
has been used by microorganisms, such as E. coli (Escherichia
coli), found in nature for millions of years, but has been
demonstrated in artificial micro-/nanosystems only in recent
years.35 The exciting possibilities of generating and controlling
propulsion forces down to the nanoscale promise a wide range
of novel applications, spanning minimally invasive surgery and
active drug delivery (Section 3.2 and 3.3).
Nevertheless, synthesis and fabrication of Au NPs (and other
nanostructures) of low symmetry, especially with well-defined
chirality, remains a tremendous challenge, because energetically
favourable geometry at the nanoscale generally exhibits a high
degree of symmetry owing to minimisation of surface energy and
crystallisation forces.
While it is diﬃcult to synthesise NPs of a chiral shape,
classical attempts of investigating chiroptical eﬀect of LSPR
relies on the attachment of enantiomerically pure chiral small
molecules onto the surface of Au NPs. After functionalisation,
the Au NPs are eﬀectively surrounded by a chiral medium,
which will induce chiroptical eﬀects, such as circular dichro-
ism, around the LSPR signal of the Au NP. However, the
induced chiroptical eﬀects in the LSPR are typically weak.36–38
Other chemical approaches were developed to achieve direct
chiroptical eﬀects of LSPR. One eﬀective route is to attach via
supramolecular self-assembly Au NPs around chiral molecular
templates which are available from natural sources or organic
synthesis. Various chiral molecular templates, including amino
acids, double-strand DNA andDNA-origami, have been investigated
regarding their eﬀectiveness on mediating the formation of chiral
assemblies of Au NPs.25,36,39–41 Notable success has been attained
by using DNA-origami scaffolds owing to their versatility and
precision in forming into a wide range of programmable 3-D
shapes. Another route towards chiroptical LSPR is to directly grow
Au NPs into chiral shapes or with chiral imprints by solution-based
synthesis. This can be achieved by growing Au NPs in the presence
of chiral-directing agents. Despite being demonstrated in NPs of a
few other materials,42–44 chemical synthesis of chiral Au NPs has
not been reported until very recently.45
On the other hand, physical methods, mostly electron-/ion-
beam-based lithography, have also been used for the fabrication
of diverse 2.5-D and 3-D chiral nanostructures.46 These methods
can be used tomake chiral structures with interesting chiroptical
properties, but they often do not permit large (wafer-) scale
processing. Yet the possibility of wafer-scale fabrication of chiral
Au NPs has been recently demonstrated using a novel nano-
fabrication technique (nano-GLAD).31 Furthermore, the resultant
chiral Au NPs (Fig. 2c) can be easily detached from the wafer
surface to form stable nanocolloidal solutions of a practical
concentration (1010 NPs per mL), shedding light on their
potential applications as solution-based chiral LSPR biosensors
(Section 3.1).
2.4 Classification of hybrid gold nanoparticles
Gold nanostructures can be generally classified into three main
categories, namely (1) homogeneous Au NPs, (2) heterogeneous
Au NPs and (3) Au NP assemblies. While categories (1) and (2)
concern individual NPs, category (3) includes assemblies of Au
NPs exhibiting collective properties that are not found in their
disassembled counterparts. From (1) to (3), there is a general
increase in length scale and material complexity owing to the
increase in the number of components made of diﬀerent materials
across the categories. The dimension of symmetry varies rather
independently both across and within the categories, with an
exception of NPs of very low symmetry, e.g. chiral NPs, which can
only be found in the larger length scale regime (Fig. 2c, f and h).
This is due to the relatively low stability of NPs of low symmetry in
the small length scale regime owing to surface and lattice eﬀects.
2.4.1 Homogeneous Au NPs. Homogeneous Au NPs refers
to NPs that contain only gold within the construct. This is
the simplest class of Au NPs, which are chemically stable, highly
biocompatible and easy to functionalise using thiol and amine
chemistry. The Au NPs are typically stabilised by a self-
assembled monolayer of ligand molecules, which prevents them
from aggregation and sintering. With the actual wavelength
depending on their size and shape, they exhibit well-defined
LSPR owing to the absence of other LSPR-damping materials.
At the low end of the length scale, Au clusters and nanoclusters
(Fig. 2a) are typically smaller than 5 nm, and exhibit weak or no
Journal of Materials Chemistry B Review
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LSPR eﬀects. They are traditionally synthesised from organo-
metallic precursors that require stringent control over reaction
conditions.47 Recent advances of micro-reactor technology
allow them to be made via facile flow synthesis.48,49 Au clusters
have been shown to have excellent antimicrobial activity.50,51
Moving up along the length scale (5–100+ nm), there exist a
wide variety of Au nanocrystals with different shapes (Fig. 2b),52
ranging from the classical spheres to cubes, plates, rods, wires
and stars. Anisotropic shapes with a large aspect ratio can shift
the LSPR to NIR wavelength which could be beneficial for
in vivo applications.
Moving down the symmetry dimension, there are chiral Au
NPs (Fig. 2c) which show unique chiroptical properties around
the LSPR wavelength.31,45
2.4.2 Heterogeneous Au NPs. Heterogeneous Au NPs are
NPs consisting of gold and at least one other material. As a
classical example in this category, core–shell NPs (Fig. 2d) are
NPs with a core of (typically) gold encapsulated inside a shell of
various materials. The shell layer can be made of polymers or
inorganic materials and can be used to enhance the chemical
and colloidal stability, biocompatibility and anti-fouling properties
of the NPs. Furthermore, it can be used to load and release drugs
on-demand upon chemical stimuli.53
When the core is only partially coated on one side or coated
by a diﬀerent material on each of the two faces, then it will lead
to a break of mirror symmetry on the NP, forming Janus NPs
(JNPs, Fig. 2e) which are named after the two-faced ancient
Roman god. The break of mirror symmetry, when coupled to
an appropriate mechanism, can lead to interesting phoretic
eﬀects, such as self-electrophoresis in Au–Pt JNPs54 and thermo-
phoretic effect in Au–SiO2 JNPs
55 and thermophoresis in Au–DNA
JNPs.56 As a basic asymmetric NP, JNPs can also serve as key
intermediates towards more complex asymmetric NPs, such as Au
NP@SiO2 nanocups.
57,58
At the higher end of the complexity dimension, heterogeneous
Au NPs can consist of multiple materials (including metals, alloys,
ceramics, magnetics and polymers) with diﬀerent material
composition and distribution, which are broadly classified as
hybrid Au NPs (Fig. 2f).59–61
2.4.3 Au NP assemblies. Au NP assemblies are ensembles
of Au NPs exhibiting collective properties and behaviours that
are diﬀerent from the individual building blocks. Additional
structural parameters are often required to describe the arrange-
ment of NPs within the assemblies, including interparticle
spacing, number of NPs per assembly and degree of ordering.
Metamolecules are discreet assemblies made of a small
number (o50) of Au NPs (Fig. 2g).62 This category embraces
the simplest forms of NP assemblies (e.g. dimers, trimers,
tetramers) which in some cases resemble the shape of small
molecules. Typically, they can confine light between their gaps,
leading to strong optical field enhancement.63 The enhanced
optical field can be coupled to vibration of molecules within the
gaps and thus making it possible for them to be detected at the
single molecular level (Section 3.1.2).
DNA-templated assemblies reside in the higher end of the
complexity axis (Fig. 2h). They have a relatively long history, but
their development has recently reached a new height, thanks to the
DNA origami techniques which can produce highly sophisticated
templates for specific attachment of Au NPs.64 Their potential
applications in the biomedical area are, however, limited by the
abundance of deoxyribonuclease (DNase) in the human body
that eﬃciently catalyses the hydrolytic cleavage of phosphodiester
linkages in the DNA backbone, thus degrading the DNA scaﬀolds.
Large scale Au NP assemblies (a.k.a. aggregates) can reach a
millimetre in size (Fig. 2i). They are often formed by controlled
aggregation of Au NPs in solution, mediated by gold-ligand
bonding,65–68 supramolecular complexation59,69 electrostatic
interactions,70 and bio-polymers/objects (incl. proteins, peptides
and viruses).64
3. Key features & applications
Novel hybrid Au NPs, engineered based on the framework as
discussed above, give rise to unique plasmonic features that can
serve as a new platform for nanomachines and robots showing
unique and multiple functions. They are poised to perform complex
tasks ranging from advanced sensing and therapy to other novel
applications. The following subsections highlight three key advanced
applications of hybrid Au NPs in plasmonic sensing (Section 3.1),
plasmonic therapy (Section 3.2), and micro- and nanomachines
(Section 3.3). Refer to ref. 4 and 18 for other possible applications
using Au NPs, e.g. biomedical imaging.
3.1 Plasmonic sensing
In bio-applications, it is desirable to have a local sensor probe for
revealing key physiochemical parameters of its immediate surround-
ings in situ or in vivo, and thus the most prominent application of
hybrid Au NPs is plasmonic biosensors.9 Since the enhanced optical
field is highly localised on the particle, it has only a small penetration
depth into the surrounding medium, which makes Au NPs an
extremely localised sensor. Crucially, such nano-sensors can be
combined with microfluidics or paper-based platform for lateral
flow assays (LFAs)71,72 or fibre-optics for in situ remote diagnosis.73–76
For instance, the LFA with antibody-conjugated Au NPs for preg-
nancy testing has been successfully integrated in our lives.71 Sensing
performance in multiplexed point-of-care testing systems is continu-
ously progressing in conjunction with advanced plasmonic sensing
schemes using various hybrid Au NPs. Thus, we focus on recent
advances in three different generic plasmonic sensing schemes,
which have potential use for in vivo or in situ sensing and imaging
and to improve the sensing performance of existing assays.
3.1.1 Extinction spectroscopy. LSPR supported by Au NPs
is sensitive to the local refractive index n surrounding a
nanoparticle (Fig. 3a).6 The change in n of the medium, which
can also be caused by surface attachment of analyte molecules,
leads to the shift in the LSPR peak position, l*. The plasmonic
sensitivity is given by,7
Sn ¼ dl

dn
¼
der
dn
der
dl
 
l
¼ 2wn
der
dl
 
l
; (1)
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where er is the real part of the dielectric function of the
plasmonic material and w is the factor describing the shape
of the particle (2 for sphere). Conventional LSPR sensors are
now poised to detect various cancers (in liver, prostate, ovary,
colon, and mutation-induced cancers), AIDS, RNA/DNA viruses,
bacteria, inflammation, immune response, microalbuminuria,
corneal dystrophy for the purpose of medical diagnosis, drug
residues and toxic components in food, and heavy metal ions in
the environment.77,78 However, so far their sensing performance
relies only on pure metal nanoparticles (e.g. Au and Ag) whose
sensitivities are typically below 1000 nm per RIU (Fig. 3b),
which are still significantly lower than those of propagating type
surface plasmon resonance (SPR) biosensors (B10000 nm per
RIU).79 Hence, for commercialisation, LSPR nanosensors require
improved sensitivity and figure of merit (FOM = sensitivity/
FWHM; full width at half maximum, e.g. the bottom panel of
Fig. 3a). Attempts in improving sensitivity and FOM have been
made via engineering two factors w and er, as shown in Fig. 3b.
According to eqn (1) higher w leads to enhanced sensitivity, for
instance by employing more elongated particles (e.g. rod and
prism, from left to right in the framework, e.g. Fig. 2b).80
However their sensitivities are typically below 1000 nm per RIU
and the resultant LSPR peaks in the NIR regime are not only
hard to resolve via general optical microscopies, but also diﬃcult
to incorporate into colorimetric sensing schemes. Meanwhile,
decreasing the wavelength dependence of the real part of the
material’s dielectric constant (proportional to the refractive
index of the NP, the denominator in eqn (1)) can also lead to
an increase in sensitivity. There are several alloyed plasmonic
NPs (e.g. Au–Ag,81,82 Au–Cu,83 and Au–Pd84), but they show little
changes in er, and therefore exhibit limited sensitivity enhance-
ment. Recently, this approach has been achieved by increasing
the material complexity (Section 2.2, from top to bottom in the
framework in Fig. 2).85 For example, mixing a plasmonic metal
with a metal possessing low dispersion in er flattens their
effective dielectric dispersion, allowing enhanced sensitivity
(41000 nm per RIU) while keeping their resonance in the visible
range. Example combinations are (but not limited to) Ag–Ti85
and Ag–MgF2.
86 However, the plasmonically inactive materials in
the nanoparticle often cause resonance damping, resulting in
large FWHM and thus low FOM.87 To address the dilemma,
exploring the optimal material mixing ratio is necessary.
An elegant way to approach this problem is to introduce
shape chirality to the NPs (as discussed in Section 2.3, from left
to right in the framework in Fig. 2). This allows the observation
of feature-rich plasmonic signals supported by chiral Au NPs
using standard chiroptical spectroscopy.31 For instance, chir-
optical LSPR response can be monitored by circular dichroism
(CD) spectroscopy, which measures the diﬀerential extinction
of the chiral NPs with left- and right-handed circularly
polarised light (Fig. 3c, see also Section 3.1.3).88 The observed
signals possess information about the bipolar nature of CD,
from which richer spectral features and zero crossings can be
extracted and analysed to yield a narrow eﬀective FWHM and
thus high FOM data (lower panel of Fig. 3c).85,89 A proof-of-
concept immunoassay based on biotin–avidin binding has
been demonstrated using CD spectroscopy on functionalised
Ag–Ti nanohelices.85 Strictly speaking, here change in the CD
spectra is due to the change in n according to the
molecular binding on the NPs and unnecessary to involve
chirality of molecules (see Section 3.1.3 for chiral molecule
sensing). Similar approaches with plasmonic meta-surfaces
have been demonstrated in conjunction with magnetic
anisotropy,90 Fano-type resonance,91 or polarisation dependent
spectroscopy.92 They can increase the sensitivity and FOM, but
their mechanisms rely on surface interactions requiring an array
Fig. 3 Plasmonic extinction spectroscopy. (a) Schematic view of plasmonic sensing. Top panel shows the plasmonic resonance of metallic
nanoparticles as a function of wavelength. Inset shows a metallic nanosphere interacts with light and generates a detectable absorption peak due to
LSPR. The bottom panel shows a zoomed-in region near the peak, illustrating how it shifts in wavelength as the refractive index of the surrounding
medium changes n1 o n2. (b) Sensitivities of plasmonic NPs reported in the literature as a function of the peak wavelength in water. The symbols and
colours are diﬀerent for the shapes and the material composition respectively (Au sphere,80 Au cube,80 Au rod,80 Au bipyramid,80 Au prism,177 Au
star,80,178,179 Ag sphere,180,181 Ag cube,182,183 Ag prism,180,184,185 core/shell (or shell),186–190 and Ag–Ti nanohelices85). (c) Circular dichroism (CD) spectra
of Ag–Ti nanohelices in media of five different refractive indices (red: 0%, orange: 5%, green: 10%, blue: 15% and violet: 20% glycerol–water mixtures)
over the full spectral range. Inset shows the TEM image of a single Ag–Ti nanohelix (scale bar 50 nm). The bottom panel shows a detailed plot of the
resonance shifts at zero-crossing. The filled curves represent |CD|1. Adapted from ref. 85 with permission. Copyright 2016 Springer Nature.
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of nanostructures, thus limiting modular sensing schemes for
in vivo applications.
3.1.2 Vibrational spectroscopy. Plasmonic metamolecules,
(Section 2.4.3, Fig. 2g), can induce regions of strong optical
near-field enhancement, known as ‘hot-spots’, Fig. 4.93 The
field enhancement can be maximised by optimising a ultrathin
dielectric gap down to B1 nm between plasmonic NPs, which
calls for highly precise ordering of individual components
(from top to bottom in the framework in Fig. 2).3,63 Coupling
this nano-gap LSPR to vibronic and electronic transitions
with the molecules facilitates sensing from single molecular
level94 to bulk multiplexing.72,95 Two representative schemes
are surface enhanced Raman scattering (SERS)96 and surface
enhanced infrared absorption (SEIRA).97 The former utilises
the plasmonic field enhancement to amplify the Raman vibra-
tional scattering features of the molecules in the gap (as scale of
104–108 SERS enhancement), enabling molecular ‘fingerprint-
ing’. Since SERS enhancement is very sensitive to material
purity and structural geometry of the NPs, sophisticated and
expensive nanolithography techniques are often required to
fabricate high-quality SERS substrates, limiting industrial
applications. A recent SERS study, however, focuses on
‘lithography-free’ self-assembly of plasmonic NPs, in particular
with a ‘glue’ molecule that is not only able to contain single
target molecule inside, but also lead to very small nanogap
plasmonics.66 For example, the nanoparticle-on-mirror (NPoM)
construct, two plasmonic systems separated by a host–guest
complex (Fig. 4a), gives rise to the strong SERS signal within the
volume below 1 nm3 (Fig. 4b),63,98 which can now be utilised as
a tool for elucidating novel optical dynamics. On the other
hand, for industrial applications, extended self-assembly has
been developed to achieve the large-scale assembled plasmonic
nanoparticles by increasing the material length scale as shown
in Fig. 2i (from upper-left to lower-right in the framework in
Fig. 2). This offers multiple hot-spots leading to in situ sensing
with high sensitivity (left and middle panels of Fig. 4c).66,99
Such a system is now able to perform in vivo multiplexing
(with animals) and paper-based SERS diagnosis of DNA and
protein biomarkers, tumour cells, blood glucose, and bacterial
pathogens,100–104 potentially via a commercial smartphone
(right panel of Fig. 4c).105
In contrast, SEIRA signals from ultra-small sample volumes
can be achieved by overlapping the plasmonic resonance with
the absorption bands of targeted molecules (Fig. 4d).95 The
resonance mode of the plasmonic antenna can be used to
confine the IR right into the nanoscale volume, and can be
engineered to overlap with the vibrational signatures of target
molecular absorption bands. This allows for simultaneous
SEIRA enhancement and detection. Crucially, compared to
SERS that necessitates extremely short detection length, SEIRA
can still be functional up to several hundred nanometres,
making this ideal for the multi-length scale detection ranging
from sub-nanometre CO molecules to proteins and lipid mem-
branes over several tens of nanometres.106,107 In particular, this
technique is expected to be key for understanding the role of
protein misfolding in incurable neurodegenerative disorders
including Alzheimer’s and Parkinson’s diseases.95 Recently,
with an advanced material perspective (from upper-left to
lower-right in the framework in Fig. 2h), the barcode-like
molecular 2-D imaging based on low loss dielectric SEIRA
structures has been developed.108
3.1.3 Chiral spectroscopy. Unlike previous sections, here
we focus on plasmonic detection of chiral molecules which are
abundant in biological systems and medicine – their chirality
has been shown to exert major impact on the patient’s health.109
Left- and right-handed chiral molecules (enantiomers) possess
Fig. 4 Plasmonic vibrational spectroscopy. (a) Illustration of a target molecule in the ‘glue’ molecule in the nanoparticle-on-mirror geometry (top panel).
The bottom panel shows the simulated near-field of the coupled gap plasmon.94 (b) Anti-Stokes/Stokes spectra at a time when additional picocavity-
induced lines are present. Colours correspond to same lines on Stokes and anti-Stokes sides, with vibrational eigenmodes and eﬀective temperatures
shown.63 (c) Left panel shows the TEM image of Au NPs aggregation with ‘glue’ molecules. Inset shows the associated numerical simulation of field
enhancement.66 The middle panel shows the SEM image of the self-assembled gold nanorods (inset: its photo in bulk).99 Right panel shows a photo of an
on-site SERS measurement using the smartphone-based Raman spectrometer.105 (d) Multi-reflection spectra of plasmonic antennas revealing the signal
deformation according to lipid membranes and protein molecules in the enhanced optical field (top panel).106 Bottom panel shows low loss dielectric
meta-pixels that overcome intrinsic metal losses, converting absorption signatures into barcode-like molecular images.108 Adapted by permission from
the corresponding references. Copyright Spring Nature, American Association for the Advancement of Science, American Chemical Society, Royal
Society of Chemistry.
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very similar physical and chemical properties, and the differences
in their properties can only be revealed under a chiral influence.
For instance, they respond differently to left- and right-circularly
polarised light. This is known as optical activity, and is defined
as the difference in the complex refractive index of a solution
containing one enantiomer of a chiral molecule in excess
N˜ = n˜0  dn˜ with dn˜ = dn + idk, where n is the refractive index
and k is the extinction coefficient of the solution.110 The differences
in the real (dn) and imaginary parts (dk), respectively, give rise
to circular birefringence (CB) and circular dichroism (CD), and
measuring those features provides a direct means of distinguishing
the handedness of the chiral molecules. Such differences are of
interest in pharmaceutical active compounds because one enantio-
mer possesses the desired property while another can have
unwanted side effects. For example, thalidomide was a treatment
(in the late 1950s) for morning sickness, but stopped selling after
ca. 10000 children suffering birth defects were born from women
taking this drug during pregnancy.111 This is due to the interaction
of the (S)-()-enantiomer with the embryo’s prenatal DNA, leading
to the birth defects in the form of missing and malformed
limbs.46,112 Thus measuring the chiroptical effects of chiral com-
pounds has great potential in pharmaceutical and drug industries,
but their associated spectral signals are inherently weak since they
depend on the change of the optical field of the light across the
dimensions of the molecule.
Chiral plasmonic NPs (on the right side of the framework in
Fig. 2) promise new sensing schemes that permit the detection
of chiral molecules. Since their structural dimensions approach
the wavelength of visible light, they give rise to strong chirop-
tical eﬀects in the visible range of the spectrum.46 Impressively,
a colloidal solution of chiral NPs show not only several orders
of magnitude stronger chiroptical eﬀects than those exhibited
by chiral molecules, but also non-linear optical activity, which
is not possible to observe from chiral molecules.113 We here
introduce two representative sensing schemes of chiral mole-
cules using hybrid Au NPs, namely superchiral sensing and
chirality transfer. Note that while the former requires chirality
of both molecule and NP, only chiral molecule is necessary for
the later (i.e. no chiral NP). The former employs the optical
field near a chiral plasmonic NP (at the right-corner of the
framework in Fig. 2). Such chiral near-field supported by chiral
NPs can give rise to an optical chirality surpassing that of
circularly polarised light, known as a superchiral field.114 This
is suggested to distinguish the chiral molecule in the chiral
near-field,115–117 but the underlying mechanism of how the
chiral near-field may interact with the chiral molecule and
affect the far-field CD spectrum is still under debate.36 On the
other hand, the approach of chirality transfer utilises Fo¨rster-
type resonance energy transfer (FRET) with plasmons.118 During
plasmonic resonance, an achiral NP (i.e. high symmetry at the
top-left corner of the framework in Fig. 2) generates a ‘hot
electron’, which is the metastable state of excited electrons,
but has no visible optical activity itself. If this plasmonic NP is
in contact with a chiral molecule, energy can be transferred to
the molecule such that the molecular optical activity can be
stimulated.119 This could be a flexible and sensitive sensing
scheme and recently Raman optical activity (ROA) has been
enhanced in this way,120 which is analogous to SERS but
potentially offers the fingerprinting of molecules in 3-D. They
however show yet inherently low signal to noise level, and
therefore require extremely active plasmonic NPs to enhance
the signal. This challenge might be overcome by using hybrid
NPs in the near future.
3.2 Plasmonic therapy
Nanoparticle-based platforms have facilitated advances towards non-
invasive treatments in medicine, through targeted therapy.121,122
In particular, Au NPs can be used for extremely localised thermal
therapy, in which light absorption is converted into heat via a
process known as plasmonic heating. By integrating multiple
functions, hybrid Au NPs can act as multipurpose nanocarriers
that perform site-specific and time-controlled drug release and
localised thermal therapy. Here we highlight how recent hybrid
Au NPs serve as advanced nano-carriers in therapeutics.
3.2.1 Local therapy using plasmonics. Au NPs can convert
absorbed light into thermal energy. Parameters of this process
(e.g. wavelength, bandwidth and eﬃciency) can be tailored
through optimising the size, shape and material (imaginary
part of the dielectric constant) of the plasmonic NPs.8 Under
given conditions (including size, number density of Au NPs and
light wavelength and power),123 the resultant plasmonic heat
can elevate the surrounding temperature to over 43 1C, suﬃ-
cient to damage and kill cancerous tissues by hyperthermia (e.g.
MGC803 human gastric cancer cell tumour as shown in
Fig. 5a).122,124 Crucially, while Au NPs can act as therapeutic
agents themselves, they can be further engineered as smart
nanocarriers to deliver and release drugs at the desired site and
time triggered by plasmonic heating (Fig. 5b).125 Here, they
generally require material complexity (Section 2.2, from top to
bottom in the framework in Fig. 2) in the form of core–shell
(Fig. 2d), Janus (Fig. 2e), or assembled NPs (Fig. 2g–i), in
conjunction with molecular cargoes such as drugs and genes.
For instance, under light exposure, Au NPs decorated with thermo-
responsive polymers can generate plasmonic heat, triggering phase
transition of the polymers.126 Poly(N-isopropylacrylamide) (PNI-
PAM) is a representative example with a phase transition tempera-
ture at B32 1C, leading to large volume change. Genes, nucleic
acids, proteins and drugs (e.g. doxorubicin, curcumin, dipyrida-
mole, insulin, 5-fluorouracil) can be trapped/expelled,127 thus
hybrid systems functionalised with PNIPAM are widely investigated
for biomedical applications.128 The versatility of hybrid Au NPs
extends to multiple and selective release depending on the wave
form of the light (Fig. 5c).129 Continuous light induces collective
heating effects of nanoparticles, causing dehybridisation and
release of single-stranded DNA (ssDNA), while pulsed light sup-
presses such a heating effect and transfers hot electrons to break
the Au–S bond, thus releasing double-stranded DNA (dsDNA). Such
selective release of DNA (or potentially RNA) can be efficiently
harnessed to prohibit transcription or translation of messenger
RNA (mRNA), making the NPs useful for applications in gene
therapy as well as drug delivery. In the near future, multi-
functional hybrid NPs are expected to play a crucial role as versatile
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nanocarriers for in vivo medical applications, especially for extre-
mely localised non-invasive therapy and surgery.
3.2.2 Targeted drug delivery. Although hybrid Au NPs show
promise as nanocarriers for local therapy as discussed above,
their use at the clinical level often remains challenging as they
suﬀer from low bio-distribution thus low treatment eﬃciency.
In most cases, distributing nanocarriers at a target site highly
relies on their diﬀusion in the target tissue and/or their
surrounding environment. Since cancerous cells and diseased
tissues possess complex and heterogeneous physicochemical
properties, such a passive diﬀusional therapy not only becomes
less-eﬀective, but may also accompany poor distribution of the
NPs in a targeted tissue due to the complexity and heterogene-
ity of biological tissues.130 To address this, hybrid Au NPs are
combined with biocompatible matter like stem cells (Fig. 6a,131
i.e. increase in the material complexity from top to bottom in
the framework in Fig. 2). This combination leads to high
bioavailability, good solubility and subsequent distribution
into the tissues.132 Nevertheless, such diﬀusion-based pro-
cesses generally require considerable time, especially in biolo-
gical materials consisting of multiple membranes that hinder
the penetration of substances into the interstitial tumour
matrix.133 In these cases, the eﬀective dose delivered to the
target region is below 1%.134 To confront this issue, controlled
target delivery is being investigated. Recently, a simple
approach using a plasmonic pen comprising Au NPs linked to
a dielectric handle (Al2O3) is used to penetrate the living cell
membrane and deliver the genes inside directly (Fig. 6b).135
The plasmonically heated Au part allows the whole body of the
nanopen to penetrate through the complex membrane and
their handle-like body delivers the ssDNA while retaining over
75% cell viability. Thus, such enhanced targeted delivery
systems should facilitate the practical usage of the hybrid Au
NPs in medicine in the near future.
3.3 Micro/nano-actuators with plasmonics
As discussed above, the unique optical interaction of hybrid Au
NPs with light can be harnessed in numerous ways. Recently
this interaction has been adopted for use in various multi-
functional nanomachines.136 Here we introduce two recent
intriguing proof-of-concept applications, namely active nanor-
heology and active cargo delivery.
3.3.1 Active nanorheology using plasmonics. Anisotropic Au
NPs including rods and helices show polarisation-dependent plas-
monic features (from left to right in the framework in Fig. 2). Their
polarisability is dominated by their physical long axis, so if the
orientation of an anisotropic NP to the incident light is control-
lable, then the associated plasmonic spectra can be modulated.15
The first demonstration relies on strong electric fields to align Au
nanorods.137 The long axis of the Au nanorods is aligned along the
direction of the external electric field due to a torque exerted by the
electric field, and thus their interactions with polarised light can be
controlled. Since this scheme requires very high field strength,
simpler schemes have been developed in conjunction with mag-
netic materials that can facilitate alignment by a weak magnetic
field.138 Combining magnetic features with plasmonics can be
achieved by making the multi-layered nanoparticles comprising
plasmonic metals with ferromagnetic materials (Fig. 7b and f)23,139–
141 or by alloying them (Fig. 7d,142 from upper-left to lower-right in
the framework in Fig. 2). Due to the natural magnetic anisotropy
along the long axis (a.k.a. the easy axis) of the anisotropic NPs,143
their long-axis can be aligned to themagnetic moment,m along the
magnetic field direction, B.
Fig. 5 Plasmonic heating for therapy. (a) Hybrid gold nanomaterials loaded with human cells for target delivery and enhanced photothermal
therapy.124 Left panel shows the TEM image of the Au core–shell NPs. (b) Photosensitiser-loaded plasmonic gold vesicles for trimodality (fluorescence,
thermal, and photoacoustic imaging) guided photo-thermal and dynamic cancer therapy.125 (c) NIR-light-induced DNA release.129 A continuous light
irradiation causes dehybridisation and release of fluorescently tagged single-stranded DNA (ssDNA), while pulsed irradiation results in Au–S bond
breakage and release of double-stranded DNA (dsDNA). Adapted by permission from the corresponding references. Copyright American Chemical
Society.
Review Journal of Materials Chemistry B
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
M
ay
 2
01
9.
 D
ow
nl
oa
de
d 
on
 8
/1
9/
20
19
 2
:2
2:
48
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
3490 | J. Mater. Chem. B, 2019, 7, 3480--3496 This journal is©The Royal Society of Chemistry 2019
The switching property is a crucial basis for their use as
nanomechanical probes. Under the rotating magnetic field
with frequency fB, viscous drag causes a phase lag f between
m and B, which is fixed to its orientation. In the steady state,
o = 2pfB, the balance of torques means that the phase angle is
related to the drive frequency according to144
sinf ¼ 2pS
mrB
ZfB; (2)
where S is a constant describing the hydrodynamic shape of the
nanoparticle (S = 8pR3 for a sphere),145 mr is the magnetic
remanence of a NP, and Z is the local viscosity. The key insight
is that, at the given magnetic field intensity and frequency, the
phase lag f can be determined by S and Z. This means if one is
constant and known, then another can be found by measuring
f. For instance, at the given Z, the total mass change (i.e. S) of a
nanorod induced bymolecular interaction (e.g. antibody–antigen
reaction) on its surface causes the increase in f, which directly
indicates the amount of antigen on the nanorod, Fig. 7c.140
On the other hand, if the probe is protected from any surface
interaction (i.e. no change in S), then viscosity becomes a sole
variable aﬀecting f and can be measured by tracking f. This is
particularly interesting when the nanoprobes are in the
complex fluids containing a mixture of multiple phases.146 In
fact, since many biological systems fall into this category, this
becomes an important consideration for medical applications.
Typically, biological complex systems possess a solid phase (e.g.
micro-particles and cells or a network of macromolecules)
dispersed in a fluid phase, so their macroscopic rheological
measurements generally show non-Newtonian viscoelastic
behaviour although the liquid phase alone is a simple New-
tonian fluid.147 It is therefore impossible to measure using
conventional macroscopic rheometers the rheological property
of the liquid without first isolating the liquid phase from the
complex media. However, local measurement of the fluid
viscosity can be possible if the total length of the probe is in
the nanoscale, which is smaller than the mesh size of the
network or the space between the micro particles.148–150 In this
case, dynamics of the nanoprobes can be decoupled with the
dispersed phase, and can be therefore used to measure their
surrounding fluidic viscosity, even within complex fluid
media.142
Fig. 6 Advanced target delivery using plasmonics. (a) Distribution of free
Au NRs and neural stem cell (NSC)-aided Au NRs after 3 days of intratumoral
injection.131 (b) Positioning and injection of functionalised plasmonic JNPs
into cells.135 Left panel shows the SEM micrograph of a JNP consisting of a
spherical Au NP (B80 nm) connected to a dielectric alumina shaft (length:
B500 nm). The Al2O3 part of the JNPs is functionalised with a fluorescently
labelled oligo-ssDNA. Adapted by permission from the corresponding
references. Copyright American Chemical Society.
Fig. 7 Active nanorheology using plasmonics. (a) A schematic of a rotating nanomotor sensor.139 (b) HR-TEM image of a Au/Fe/Au nanorod and its
corresponding elemental false-colour mapping images. (c) FFT plots of the extinction signals of the Au/Fe/Au nanoprobes under a magnetic field rotating
at 3.33 Hz (black: bare probe, red: probe with antibody, blue: probe with antibody-antigen reaction).140 (d) TEM image of the 2-turn Au–Fe nanohelix with
ca. 170 nm in height. Schematic depicting a rotating magneto-plasmonic nanoprobe in a complex and optically dense medium (here blood plasma
surrounded by erythrocytes). (e) In situ active nanorheology in blood. The top panel shows the extinction and CD spectra of the colloidal Au–Fe
nanohelices as a function of wavelength in bovine blood plasma surrounded by the erythrocytes at different volume fractions (top, 0%; middle, 33%;
bottom, 50%). The bottom panel shows the measured dynamic viscosity of the bovine blood plasma in the presence of red blood cells with different
hematocrit level.142 (f) Schematic of the Co/Au nanodomes with out-of-plane magnetisation (left panel). The right panel shows HR-TEM image of the
nanodomes with the Co/Au multilayers.23 Adapted by permission from the corresponding references. Copyright Wiley-VCH, American Chemical Society.
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There exist additional considerations in performing optical
measurements in complex media. Optical signals can be hugely
attenuated and perturbed by the absorption and scattering of
the dispersed solid phase. This explains why it is extremely
challenging to extract meaningful optical signals from any
optical probes in whole human blood which contains a high
level of highly light-absorbing red blood cells. Hence conven-
tional optical sensing is performed in blood plasma without
any cells. For direct optical measurement in complex media,
innovative approaches are needed to generate optical, spectral
or phase contrast against a complex and strongly attenuating
background. When coupled with a modulating external magnetic
field, polarisation-dependent optical properties of anisotropic NPs
can be employed to generate phase contrast in the frequency
domain. This approach has been employed in gyromagnetic
imaging. Identification and tracking of Au nanostars with a
magnetic core inside tumour cells were achieved using broad-
band excitation.151 Moreover, this approach can be extended by
using chiral NPs of Au–Fe (Fig. 7d). In particular, the CD signal
of Au–Fe nanohelices is background-free as it is insensitive to
achiral objects. External magnetic modulation of these magnetic
nanohelices allow the direct measurement of blood plasma
viscosity in whole blood (optical density ofB3, Fig. 7e).142 This
scheme can be further applied to fluids with non-Newtonian
properties such as living cells.152
3.3.2 Active cargo delivery. The challenges in micro and
nanorobots so far have been the development of general
methodology for powering these small objects to actively move
through the human body and for integrating other functions to
perform complicated tasks like their macroscopic counterparts.153
Diverse plasmonic-driven actuators have been developed including
light-induced rotors using chiral NPs (at the right side of the
framework in Fig. 2),154 light-driven thermophoretic55,155,156
or photocatalytic motors56,157,158 based on JNPs (e.g. Au–SiO2,
Au–polymer, and Au–TiO2), and self-propelling actuators pow-
ered by repeating the shape deformation (swelling/deswelling)
of the thermo-responsive polymer (PNIPAM) surrounding Au
NPs in response to the plasmonic heating.159,160 These
plasmonic-driven actuations, in particular thermophoresis, have
been demonstrated in HeLa cells under NIR laser irradiation
with no detectable damage to the cells.156 Nevertheless, while
many micro- and nano-actuators have been reported,161–163 only
a few schemes have simultaneously demonstrated the capability
of self-propelling in biological fluids and performing tasks on
top of propulsion. Recently, a hybrid micro-propeller system
shows impressive success in addressing these challenges. The
system is based on a silica micro-helix scaffold containing a
ferromagnetic segment for magnetic propulsion (Fig. 8).35 Here,
the magnetic moment m along the long axis of the magnetic
segment is orthogonal to the long axis of the whole helix body. At
the frequency fB of the rotating magnetic field B below the step-
out value, the helix rotates synchronously and move forward in
liquid.35 These micro-propellers are now able to propel in
mucus,164 living cells,165 and eyes (Fig. 8a).166 Importantly, the
hybrid NPs can also be combined with plasmonic trapping to
performmultiple tasks and thus serving as ‘‘smart’’ micro-robots
(Fig. 8b).167 The plasmonic patches are formed along the body of
the helix and can induce hot-spots under light illumination
(Fig. 8c). These hot-spots generate optical near-field gradients
that attract and trap the target bacteria surrounding the body of
the micro-propellers. Since both actuation and trapping are
independently controllable by using magnetic and optical fields
respectively, the target object (here bacteria) can be delivered to
the target area by the aid of plasmonics (Fig. 8d).
4. Conclusion & perspective
Thanks to remarkable recent advances in nanoparticle synthesis
and fabrication, underpinned by progress in characterisation
techniques and fundamental theories, novel hybrid gold nano-
particles (Au NPs) demonstrate unprecedented physicochemical
properties and multi-functionality, promising great potential for
diverse biomedical applications.
The development trend of Au NPs in academia can be
reflected in the number of publications containing this and
other closely related key words (Fig. 9a). Overall this area of
research is booming with number of publications reaching 104
per year. It is interesting to note, however, that the share of Au
NPs within the NP literature is slightly declining over the past
decade, accompanied by the raise in the share of hybrid Au NPs
within the Au NP literature (Fig. 9b). This observation indicates
that the focus of the field is shifting towards the development
of complex multicomponent NPs.
Fig. 8 Micro-actuators with plasmonic trapping. (a) Schematic showing the
injection of the helical micro-actuators inside the eye and actuate them via the
external magnetic field.166 (b) Integration of plasmonic NPs with the helical
micro-actuators.167 (c) Schematic depicting how the micro-actuator with
plasmonic trapping can be functional for active cargo delivery. The bacteria
can be trapped and released by light and their actuation can be controlled
independently by external magnetic field. (d) Corresponding experimental
demonstration. Adapted by permission from the corresponding references.
Copyright American Association for the Advancement of Science.
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The rapid and diverse evolution in the hybrid Au NPs
motivates us to shape a new classification framework of the
hybrid Au NPs based on their fundamental dimensions (length
scale, material complexity, and symmetry, Fig. 2). Categorisa-
tion systems such as this could help demystify the wide range
of materials available and provide a systematic tool for design-
ing new nanomaterials. In the practical aspects, the framework
can facilitate convenient comparison and benchmarking of
novel Au NPs against well-established Au NP systems. Moreover
it could also aid reflection on the future direction of Au NP
research with regards to the balance between exploring
complex new materials and exploiting well understood existing
materials in both fundamental and practical contexts.
In the latter part of the review, we have discussed how the
novel physiochemical properties of hybrid Au NPs can potentially
be translated to clinical applications, illustrated by recent proof-of-
concept examples in biosensing, photodynamic therapy, gene &
drug delivery, nanorheology and minimally invasive surgery.
Despite the huge volume of research on the topic (as seen in
Fig. 9), the number of Au NP systems finding their way into
clinical trials (or other general use) remains insignificant.168
Currently, in vivo use of Au NPs have not been approved by the
Food and Drug Administration (FDA).169 Approval of clinical
use of hybrid Au NPs will be even more challenging to obtain,
because the combined toxicity from other components is often
hard to characterise in the human body. Encapsulating the hybrid
Au NPs within an inert shell (including PEG170 and silica20) might
provide an eﬀective solution,60 but their body clearancemechanism
is still not fully elucidated, leaving potential risk of bioaccumula-
tion and chronic toxicity. Nevertheless, hybrid Au NPs could find
easier translation in in vitro applications. Novel plasmonic sensing
schemes (Section 3.1) can be readily implemented in and enhance
the capabilities of existing point-of-care technologies, including
LFA and hand-held SERS biosensors.
To accelerate the translation and deployment of hybrid Au
NPs and the corresponding technologies in the biomedical
context, the field calls for cheap, decentralised and high
throughput approaches for toxicity screening and intracellular
detection of nanomaterials.171 Standard operating procedures
(SOPs) of testing should be established within the scientific
community and test results should be stored in open-access
databases supported by social enterprises or governments
initiatives.
On the front of fundamental science, it might be interesting,
and perhaps useful, to perform systematic studies on biocom-
patibility and pharmacokinetics of hybrid Au NPs at the cellular,
tissue and animal level, with an aim to extract high-level insights
into how hybrid Au NPs interact with biological systems compared
to the corresponding individual components. This type of work will
benefit from state-of-the-art characterisation techniques. For
instance, liquid-cell transmission microscopy (LC TEM)172 emerges
as a powerful technique for mapping Au NPs within a living cell
with unparalleled spatial resolution. Meanwhile optical microscopy
based on non-linear optics, e.g. pump–probe four-wave mixing
imaging,173 offers a promising avenue towards in situ 3-D tracking
of single NPs with impressive spatiotemporal resolution.
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